Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAMP3 | O60896 | 15/20 | 0.59 |
| ▸ | CALCR | P30988 | 15/20 | 0.59 |
| ▸ | F2 | P00734 | 4/20 | 0.56 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31118841 | 0.97 | RAMP3 (0.61) | RAMP3CALCRF2CXCR4 | |
| SCHEMBL31118810 | 0.94 | RAMP3 (0.61) | RAMP3CALCRF2CXCR4 | |
| SCHEMBL31031602 | 0.90 | F2 (0.59) | RAMP3CALCRF2CXCR4 | |
| SCHEMBL30884598 | 0.90 | RAMP3 (0.61) | RAMP3CALCRF2CXCR4 | |
| SCHEMBL30884605 | 0.89 | RAMP3 (0.59) | RAMP3CALCR | |
| SCHEMBL30063039 | 0.89 | RAMP3 (0.60) | RAMP3CALCR | |
| SCHEMBL31514338 | 0.88 | APLNR (0.60) | RAMP3CALCRF2 | |
| SCHEMBL31307221 | 0.88 | C5AR1 (0.57) | RAMP3CALCRCXCR4 | |
| SCHEMBL29771673 | 0.88 | NPY2R (0.65) | RAMP3CALCRCXCR4 | |
| SCHEMBL30884597 | 0.88 | C5AR1 (0.60) | RAMP3CALCRCXCR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4304717-A1 | USE OF NADOLOL TO TREAT CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY BLOCKAGE OF THE ARRESTIN-2 PATHWAY | Chronic Airway Therapeutics Limited (AU) | 2024-01-17 | — | — | EP | disclosed |
| WO-2022192252-A1 | USE OF NADOLOL TO TREAT CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY BLOCKAGE OF THE ARRESTIN-2 PATHWAY | CHRONIC AIRWAY THERAPEUTICS LIMITED (AU) | 2022-09-15 | — | — | WO | disclosed |